Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBIT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBIT Margin for 2 consecutive years, with 5773.71% as the latest value for Q1 2024.

  • Quarterly EBIT Margin changed N/A to 5773.71% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 26806.37% through Dec 2024, changed N/A year-over-year, with the annual reading at 26805.58% for FY2024, 2678756.0% down from the prior year.
  • EBIT Margin for Q1 2024 was 5773.71% at Artiva Biotherapeutics, down from 539.06% in the prior quarter.
  • The five-year high for EBIT Margin was 539.06% in Q4 2023, with the low at 5773.71% in Q1 2024.